Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF2R | P11717 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TK1 | P04183 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16084863 | 1.00 | IGF2R (0.36) | IGF2RCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL17531586 | 1.00 | IGF2R (0.36) | IGF2RCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL16154497 | 0.89 | ALDH1A1 (0.39) | IGF2RCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL16145424 | 0.89 | ALDH1A1 (0.39) | IGF2RCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL14704264 | 0.89 | ALDH1A1 (0.39) | IGF2RCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL30163856 | 0.89 | ALDH1A1 (0.39) | IGF2RCHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL24721233 | 0.88 | ALDH1A1 (0.41) | IGF2RTSHRTK1 | |
| SCHEMBL16084870 | 0.88 | ALDH1A1 (0.41) | IGF2RTSHRTK1 | |
| SCHEMBL16154509 | 0.88 | ALDH1A1 (0.41) | IGF2RTSHRTK1 | |
| SCHEMBL30465016 | 0.88 | ALDH1A1 (0.41) | IGF2RTSHRTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113575770-B | Application of ascaroside in preparation of preparation for promoting recovery and development of nematodes in S.carpocapsuae All infection period | 广东省科学院动物研究所 | 2026-05-22 | — | — | CN | claimed |
| CN-119606993-A | Application of ascaroside in preparing medicine for treating tumor | 中国科学院动物研究所 | 2025-03-14 | — | — | CN | claimed |
| EP-4444099-A2 | COMPOSITIONS AND METHODS FOR PROMOTING SOIL MICROBIALS FOR PLANT HEALTH AND STRESS TOLERANCE | The United States of America as represented by the Secretary of Agriculture (US) | 2024-10-16 | — | — | EP | claimed |
| EP-4408173-A1 | PHEROMONE COMPOSITIONS, METHODS OF MAKING, AND THEIR USES | Pheronym Inc. (US) | 2024-08-07 | — | — | EP | claimed |
| CN-113796460-B | Application of ascaroside in preparation of preparation for promoting recovery and development of nematodes in H.indica LN2 infection period | 云南省烟草公司玉溪市公司 | 2023-07-18 | — | — | CN | claimed |
| WO-2023107435-A2 | COMPOSITIONS AND METHODS FOR PROMOTING SOIL MICROBIALS FOR PLANT HEALTH AND STRESS TOLERANCE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-06-15 | — | — | WO | claimed |
| WO-2023055588-A1 | PHEROMONE COMPOSITIONS, METHODS OF MAKING, AND THEIR USES | PHERONYM, INC. (US) | 2023-04-06 | — | — | WO | claimed |
| CN-113575770-B | Application of ascaroside in preparation of preparation for promoting recovery and development of nematodes in S.carpocapsuae All infection period | 广东省科学院动物研究所 | 2026-05-22 | — | — | CN | disclosed |
| EP-4742895-A2 | ASCAROSIDES AND INSECTICIDE COMBINATIONS AND METHODS FOR USE | Ascribe Bioscience Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4735460-A2 | ASCAROSIDES AND HERBICIDAL COMBINATIONS AND METHODS FOR USE | Ascribe Bioscience Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4723893-A2 | COMPOSITIONS AND METHODS TO MITIGATE PHYTOTOXIC EFFECTS OF AGRICHEMICALS | Ascribe Bioscience Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025226798-A1 | MODIFIED ASCAROSIDES | Ascribe Bioscience Inc. (US) | 2025-10-30 | — | — | WO | disclosed |
| US-20250287946-A1 | MODIFIED RELEASE OF ASCAROSIDES | Ascribe Bioscience Inc. | 2025-09-18 | — | — | US | disclosed |
| WO-2023212362-A1 | MODIFIED RELEASE OF ASCAROSIDES | Ascribe Bioscience Inc. (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023196636-A1 | METHODS OF TREATING PLANT-BASED PRODUCTS TO REDUCE MICROBE PROLIFERATION AND EXTEND SHELF LIFE | Ascribe Bioscience Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
| CN-113796460-B | Application of ascaroside in preparation of preparation for promoting recovery and development of nematodes in H.indica LN2 infection period | 云南省烟草公司玉溪市公司 | 2023-07-18 | — | — | CN | disclosed |
| WO-2023115054-A1 | METHODS OF SEED AND PLANT TREATMENT TO REDUCE FOODBORNE ILLNESS | ASCRIBE BIOSCIENCE (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023107435-A2 | COMPOSITIONS AND METHODS FOR PROMOTING SOIL MICROBIALS FOR PLANT HEALTH AND STRESS TOLERANCE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023055588-A1 | PHEROMONE COMPOSITIONS, METHODS OF MAKING, AND THEIR USES | PHERONYM, INC. (US) | 2023-04-06 | — | — | WO | disclosed |
| US-20220409650-A1 | COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA | HOLOCLARA INC (US) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250287946-A1 | MODIFIED RELEASE OF ASCAROSIDES | ABCC1, NLRP3, NOD1 | IGF2R 1578/4885CHRM5 2185/4885CHRM1 2839/4885 |
| US-20220409650-A1 | COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA | SI, FABP2, ALPI | IGF2R 2702/4885CHRM5 3540/4885CHRM1 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.